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Summary
 
A system to innocuously visualize T cell lineage commitment is described. Using a “knock-in”
approach, we have generated mice expressing a 
 
b
 
-galactosidase reporter in place of CD4; ex-
pression of 
 
b
 
-galactosidase in these animals appears to be an accurate and early indicator of
CD4 gene transcription. We have exploited this knock-in line to trace CD4/CD8 lineage
commitment in the thymus, avoiding important pitfalls of past experimental approaches. Our
results argue in favor of a selective model of thymocyte commitment, demonstrating a funda-
mentally symmetrical process: engagement of either class of major histocompatibility complex
(MHC) molecule by a differentiating CD4
 
1
 
CD8
 
1
 
 cell can give rise to T cell antigen receptor
(TCR)
 
hi
 
 thymocytes of either lineage. Key findings include (
 
a
 
) direct demonstration of a sub-
stantial number of CD4-committed, receptor/coreceptor-mismatched cells in MHC class II–
deficient mice, a critical prediction of the selective model; (
 
b
 
) highly efficient rescue of such
“mismatched” intermediates by forced expression of CD8 in a TCR transgenic line, and an ex-
planation of why previous experiments of this nature were less successful—a major past criti-
cism of the selective model; (
 
c
 
) direct demonstration of an analogous, though smaller, popula-
tion of CD8-committed mismatched intermediates in class I–deficient animals. Finally, we
found no evidence of a CD4 default pathway.
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b
 
-galactosidase
 
M
 
ost conventional T lymphocytes fall into two classes—
MHC class II–restricted, CD4
 
1 
 
helper, and MHC
class I–restricted, CD8
 
1 
 
cytotoxic cells. Precursors of both
classes differentiate in the thymus, according to an elaborate
program classically visualized by following changes in ex-
pression of cell surface markers, in particular the CD4 and
CD8 coreceptors (1, 2). The most immature thymocytes
express no (or very little) CD4 or CD8 and are thus termed
double-negative (CD4
 
2
 
CD8
 
2
 
; DN)
 
1
 
 cells; they also dis-
play no 
 
a
 
/
 
b
 
 TCR on the surface. DN thymocytes differ-
entiate into double-positive (CD4
 
1
 
CD8
 
1
 
; DP) cells, most
of which express low levels of surface TCR. Only 3–5% of
DP thymocytes survive the transition to end-stage single-
positive (SP) cells (3, 4) committed to either the CD4
 
1
 
 or
CD8
 
1
 
 lineage and expressing high levels of TCR.
Survival and commitment at the DP stage of thymocyte
differentiation are dictated by positive selection events that
depend critically on specific interaction between the thy-
mocyte’s TCR and MHC molecules expressed on thymic
stromal cells. Experiments involving TCR transgenic (tg)
mice have demonstrated that DP thymocytes expressing class
I–reactive TCRs are selected to become CD8
 
1
 
 cells (5–7),
whereas those displaying class II–reactive receptors differen-
tiate into CD4
 
1
 
 cells (8, 9). Thus, lineage commitment is an
inseparable by-product of the positive selection process, the
specificity of the TCR being matched to a particular class of
MHC molecule and thereby to a particular coreceptor.
The mechanism by which this match is achieved and the
nature of the signals directing CD4/CD8 lineage commit-
ment remain unclear. For several years, discussions have
crystallized around the issue of whether lineage choice is
primarily instructive (directed by the TCR–MHC interac-
tion) or selective (decided after an initially noncommittal
TCR–MHC interaction), or is some combination of the
two. A series of studies on MHC-deficient and TCR tg
mice had concluded that DP thymocytes expressing a class
I–reactive TCR can commit to either the CD4
 
1
 
 or CD8
 
1
 
1
 
Abbreviations used in this paper:
 
 
 
b
 
2m, 
 
b
 
2-microglobulin; B6, C57Bl/6;
 
b
 
gal, 
 
b
 
-galactosidase; DN, double-negative; DP, double-positive; ES,
embryonic stem; FDG, fluorescein digalactopyranoside; I
 
0
 
, MHC class
I-negative; II
 
0
 
, MHC class II–negative; I
 
0
 
II
 
0
 
, MHC double-deficient;
PGK, phosphoglycerate kinase; RT, reverse transcriptase; SP, single-posi-
tive; tg, transgenic.
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lineage (10–14); the same appeared true of DP cells with a
class II–reactive receptor (10, 15–17). These conclusions,
in line with a selective mechanism of lineage commitment,
were based mainly on two kinds of observations. First, inter-
mediate thymocyte populations (CD4
 
1
 
CD8
 
int
 
, CD4
 
int
 
CD8
 
1
 
)
were described, apparently composed of cells in transit be-
tween the DP and SP compartments and including a frac-
tion with mismatched receptors and coreceptors (10, 15,
16). Second, it was possible to “rescue” a population of
mature lymphocytes seemingly derived from these “mis-
taken” thymocytes by forcing expression of the appropriate
coreceptor (14, 15). In most of these studies, lineage com-
mitment was assessed by one of two criteria: reduced sur-
face expression of one of the coreceptors after positive
selection, and helper or cytotoxic function of mature lym-
phocyte descendents in cases where terminal differentiation
was (or was made) possible.
Unfortunately, results from more recent experiments have
seriously undermined these conclusions, in particular the reli-
ance on surface levels of coreceptor to identify intermediate
populations and to serve as a marker of lineage commitment.
For example, when the class I–reactive population of CD4
 
1
 
CD8
 
int
 
 thymocytes from MHC class II–deficient mice was
injected into wild-type thymi, only CD8
 
1
 
 thymocytes were
eventually recovered (18–20). Furthermore, when the same
population was analyzed via an assay based on protease strip-
ping and coreceptor reexpression, it appeared that many
CD4
 
1
 
CD8
 
int
 
 cells had turned off CD4 but not CD8 transcrip-
tion (21, 22). These findings argued for greater complexity
during the positive selection process, and demonstrated that
surface coreceptor levels can be tardy and potentially mislead-
ing indicators of gene activity and lineage commitment.
However, intrathymic cell transfers and coreceptor reex-
pression assays are themselves potentially artifactual, as they
entail manipulation of surface molecules (i.e., cross-linking,
proteolysis) that could easily alter experimental outcome.
Thus, the mechanism of lineage commitment is still a con-
tentious issue, but it remains an important one as a frame-
work for understanding the positive selection decision-
making process at the molecular level. Therefore, we
sought to develop a system for visualizing T cell commit-
ment ex vivo in an innocuous manner. We searched for a
reporter of gene activity that could be detected easily with-
out perturbing manipulations and whose expression would
be independent of transport or stability of the coreceptors.
We report here the generation of mice with the LacZ gene
targeted into the CD4 locus and experiments exploiting
them to study CD4/CD8 lineage commitment.
 
Materials and Methods
 
Construction of the Recombinant Vector and Production of CD4
 
1
 
/L
 
Mice.
 
To obtain CD4
 
1
 
/L
 
 mice, we constructed a targeting vec-
tor as illustrated in Fig. 1. In brief, a 7.8-kb AvrII-SphI genomic
fragment from the CD4 locus was subcloned. A 323-bp fragment
containing most of exons 2 and 3 (including a 30-bp intron) was
deleted, and three cloning sites (XhoI, EcoRI, and XbaI) were
inserted by single-strand mutagenesis. The fragment’s coding po-
tential was interrupted by insertion of the 4.3-kb 
 
b
 
geo cassette
(with its splice acceptor, Kozak ATG, and polyA tail, and multi-
ple cloning sites [23]) into the XhoI site of exon 2 immediately
before the CD4 ATG site, so that exon 2 begins and ends as fol-
lows: 5
 
9
 
-GCTCAGATTCCCAACCAACAAGAGCTC-3
 
9
 
. The
1.8-kb phosphoglycerate kinase (PGK)-neo cassette (containing
the PGK promoter, a polyA tail, and cloning sites [24]) was in-
serted in reverse orientation immediately downstream of the
 
b
 
geo cassette between XhoI and EcoRI sites. The PGK-neo cas-
sette was thus fused to the remainder of exon 3: 5
 
9
 
-XbaI-TCT-
GGGGCAGCATGGCAAAGGTGTATTAATTAGAG-3
 
9
 
.
The resulting vector was linearized and electroporated into D3
embryonic stem (ES) cells as described (25). Of the 100 G418-
resistant D3 clones analyzed, 6 carrying the predicted integration by
homologous recombination were identified. Using an XhoI-SphI 5
 
9
 
external probe, we considered a clone positive if it contained the
normal 15-kb band plus an additional 9.6-kb band after XhoI diges-
tion and Southern blotting. The positive clones were secondarily
confirmed using an internal neo probe. Clone VE34 was expanded
and injected into C57Bl/6 (B6) blastocysts, which were reimplanted
into pseudopregnant females. Chimeras were crossed onto B6 mice
to obtain germline transmission, and offspring carrying the mutation
were maintained in a conventional animal facility.
“Homozygous” CD4
 
0/L
 
 mice were produced by crossing the
CD4
 
1
 
/L
 
 line with heterozygous CD4-deficient (CD4
 
1
 
/0
 
) mice (26).
 
Antibodies, Cytofluorimetric Analyses, and Cell Sorting.
 
The fol-
lowing antibodies were used: FITC-labeled anti-CD8
 
a
 
, biotinylated
anti-CD8
 
a
 
, PE-labeled anti-CD4 (Caltag Laboratories, Inc., Bur-
lingame, CA); KT3, specific for CD3 (27); T3.70, specific for the 
 
a
 
chain of the transgene-encoded HY TCR (gift of H. von Boehmer,
Institut Necker, Paris, France [5]); and B-20.1, specific for V
 
a
 
2 (28).
Texas Red–conjugated anti–rat antibodies and streptavidin-Cy5
were purchased from Jackson ImmunoResearch Laboratories (West
Grove, PA) or Caltag Laboratories, Inc. Staining of thymocyte and
lymph node cell suspensions was performed as described (25).
Three- to five-color flow cytometric analyses were performed
on a cytometer (Elite; Coulter Corp., Hialeah, FL) equipped with
4 decade logarithmic amplifiers. List mode data were collected on
5 
 
3 
 
10
 
4
 
 or 10
 
5
 
 cells.
 
Fluorescein Digalactopyranoside Staining.
 
Fluorescein digalacto-
pyranoside (FDG) staining was adapted from Nolan et al. (29). In
brief, 4–6 
 
3 
 
10
 
6
 
 cells were stained, washed, and resuspended in
120 
 
m
 
l PBS. FDG (Molecular Probes, Inc., Eugene, OR, or
Sigma Chemical Co., St. Louis, MO) at the stock concentration
of 100 mM in H
 
2
 
O/DMSO/ethanol, 1:1:1 (vol/vol), was diluted
to a working condition of 7.5 mM with H
 
2
 
O. Both cells and di-
luted FDG were warmed to 37
 
8
 
C for 5 min. 80 
 
m
 
l of warmed
FDG was added to cells while gently vortexing. Cells were incu-
bated for 5 min at 37
 
8
 
C. FDG loading was stopped by adding 2
ml of ice-cold PBS. Cells were kept on ice for 5 min, then trans-
ferred to a 15
 
8
 
C water bath for 15–30 min to enhance 
 
b
 
-galac-
tosidase (
 
b
 
gal) activity. Cells were then ready to analyze, or were
kept on ice until analysis by flow cytometry.
 
Immunoprecipitation Experiments.
 
Thymocyte suspensions were
washed three times with methionine-free DME (GIBCO BRL,
Gaithersburg, MD) supplemented with 5% FCS. Cells were la-
beled with [
 
35
 
S]methionine (
 
z
 
1,200 Ci/mmol; Amersham Phar-
macia Biotech, Inc., Piscataway, NJ) at 10
 
7
 
 cells/ml/1 mCi. To
begin the chase, thymocytes were washed with DME containing
10
 
3
 
 cold methionine, and then recultured in DME (plus 5%
FCS, 10
 
3
 
 cold methionine) for the different time points. At each
time point, aliquots (10
 
7
 
) of cells were washed twice with PBS
and frozen as pellets in liquid nitrogen. Frozen pellets were lysed 
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Figure 1. Production of
CD41/L mice. A 326-bp frag-
ment containing most of exons 2
and 3 (including a 30-bp intron)
was deleted and replaced by the
bgeo and neo cassettes. The 59
external probe, an XhoI-AvrII
fragment, detects an endoge-
nous 15-kb XhoI band on
Southern blots of DNA from
wild-type D3 ES cells and a
smaller 9.6-kb band on blots of
DNA from cells carrying the
knock-in mutation. Exons are
marked with roman numerals,
untranslated regions by open
boxes, and translated regions by
filled boxes. Arrows below the
cassettes represent their 59 to 39 orientation. Bent arrows mark the transcription initiation sites. Restriction enzyme sites are abbreviated as follows: X
(XhoI), B (BamHI), A (AvrII), S (SphI), H (HindIII), E (EcoRI), Sp (SpeI), Sm (SmaI), P (PstI), C (ClaI), Xb (XbaI), Sa (SalI), Sc (SacI), and Bg (BglII).
 
with 1 ml lysis buffer (50 mM Tris, pH 7.4, 150 mM NaCl, 1%
Triton X-100, plus protease inhibitors) on ice for 30 min. After
lysis, supernatants were cleared of cellular debris by centrifugation
at 13,000 rpm for 15 min. Cell lysates were precleared twice for
30 min with 25 ml (50%) rat serum–coupled protein G–Seph-
arose 4FF (Amersham Pharmacia Biotech, Inc.). The first incuba-
tion was usually overnight. The precleared lysate was then pre-
cipitated for 1 h with protein G coupled to GK1.5 (specific for
CD4 [30]) or anti-
 
b
 
gal (Promega Corp., Madison, WI). As a
control, precipitations were prepared with rat serum–coupled
beads. Immunoprecipitations were washed three times with 1 ml
lysis buffer (at 0.2% Triton X-100), then once with PBS.
25 
 
m
 
l of Laemmli buffer (60 mM Tris, pH 6.8, 2% SDS, 10%
glycerol, 5% 2-ME, 0.001% bromophenol blue) was added to
each immunoprecipitation. The samples were heated for 5 min at
100
 
8
 
C and then loaded and run on a 10% SDS-PAGE gel. Signals
on the gel were enhanced using Enlightning (NEN Life Science
Products, Boston, MA) after running and were quantified with a
Bio Imaging Analyzer (Fuji Photo Film Co., Tokyo, Japan).
 
Reverse Transcriptase PCR.
 
RNA was isolated from sorted
cells by standard techniques. In brief, RNA was prepared by NP-40
lysis from 1–5 
 
3 
 
10
 
4
 
 sorted cells to which 10
 
6
 
 HeLa cells were
added as carrier. cDNA was synthesized by reverse transcriptase.
Serial dilutions of the cDNA were then used as a template for
PCR amplification with specific primers for CD8 (5
 
9
 
-ATGGA-
CGCCGAACTTGGTCAGAAGGTG-3
 
9
 
 and 5
 
9
 
-CCACGTTA-
TCTTGTTGTGGGATGAAGCC-3
 
9
 
) and TCR-
 
b
 
 (5
 
9
 
-GGCA-
AGGAGGTCCACAGTGGGGTCAGC-39 and 59-GGCCAC-
TGACCAGCACAGCATATAGGGTGG-39). After amplification
(5 min at 948C; 30 cycles of 948C 30 s, 508C 30 s, 728C 1 min;
10 min at 728C), the products were run on agarose gels, trans-
ferred, and detected by hybridization using CD8- or TCR-b–
specific oligonucleotides (59-GGTGGGCTGGGGGAGTTTG-
GAGCTGG-39 and 59-GAACATCAGTGCAGAGGCCTGGG-
GCCGAGC-39, respectively). Signals were quantified using a Bio
Imaging Analyzer. Amplification of both CD8 and TCR-b were
performed in the same PCR tube.
Results
Generation of CD41/L Mice. To provide a convenient
and harmless means of monitoring CD4 gene activity, we
set out to confer a protein reporter with an identical pat-
tern of expression. bgal seemed a good reporter candidate
because it is easy to visualize, is inert, and, being cytoplas-
mic, possesses no signaling capacity, a disadvantage of most
cell-surface reporters (31, 32). We chose a “knock-in” ap-
proach rather than transgenesis of a promoter–reporter
construct in order to mimic as closely as possible the com-
plex transcriptional controls on the native CD4 gene (33–37).
Thus, mice expressing bgal in place of CD4 were gener-
ated by targeting a bgal coding region into the CD4 locus
via homologous recombination in ES cells (Fig. 1). To en-
sure faithful expression of the bgal reporter (and to inacti-
vate the CD4 gene at the same time), we introduced the
bgal coding sequences exactly at the CD4 initiation codon
in exon 2. The inserted sequence directs the translation of a
fusion protein comprised of bgal and the neomycin (neo)
resistance domain (bgeo, chosen because it is known to be
expressed in normal T cells [23]); the insert also contains an
expressible neo gene under an independent PGK promoter
for selection of ES cell transfectants (Fig. 1).
The final construct was electroporated into ES cells, and
G418-resistant clones carrying the specific homologous re-
combination event were selected. Chimeras generated
from the injection of a positive clone into B6 blastocysts
were mated with B6 females to obtain germline transmission
of the knock-in mutation. The resulting mouse line was
generally kept in heterozygous form (CD41/L; hereafter “1”
designates the wild-type CD4 locus, “L” our targeted CD4-
bgal insertion, and “0” the original CD4 knockout mutation
of Killeen et al. [26] used in some of the crosses). In the
heterozygotes, both bgal and CD4 (at half normal levels;
data not shown) should be simultaneously expressed under
the influence of elements that control the CD4 locus.
It was first necessary to determine just how closely the
expression of bgal matched that of CD4. Lymph node cells
and thymocytes were stained with FDG to detect cytoplas-
mic bgal expression (29) in addition to antibodies against
CD4, CD8, and CD3, and were analyzed by flow cytome-
try (Fig. 2). bgal expression was essentially superimposable2324 Tagging T Cells of the CD4 Lineage
with that of CD4 in both primary and secondary lymphoid
organs. In the lymph nodes, CD41 cells expressed high
levels of bgal, whereas CD81 and non-T cells expressed
low to background levels (Fig. 2 A). Similarly in the thy-
mus, CD4 SP and CD41CD81 DP cells were bgal1,
whereas mature CD8 (CD3hi) SP and immature DN cells
were not (Fig. 2 B). bgal did not appear in only a select
subset of CD41 T cells: for example, the minor (and pecu-
liar) NK1.11CD41 subset of a/b T cells (38) was also
bgal1 in thymic and spleen cell suspensions of CD41/L
mice (not shown). Importantly, bgal expression did not de-
tectably alter thymus cellularity or population distributions,
as assessed with a panel of markers including CD3, CD4,
CD8, CD69, CD24, CD5, CD44 and peanut agglutinin–
binding polysaccharides (not shown).
Upon closer examination, we noticed some interesting
features of the expression of the bgal reporter. First, CD32
thymocytes within the CD8 SP population, the immediate
precursors of DP cells, were bgal1, implying that enzy-
matic activity was detectable earlier than surface expression
of CD4 (Fig. 2 B). Second, a proportion of the CD41
CD81CD3hi thymocytes expressed low levels of bgal, sug-
gesting that reporter activity was downregulated earlier
than surface CD4 upon positive selection. These observa-
tions argued that bgal levels responded faster to changes in
transcriptional activity at the CD4 locus than the level of
CD4 protein itself. To test this hypothesis, we compared
the turnover of CD4 and bgal proteins (Fig. 2 C). In vitro
metabolic labeling with [35S]methionine and precipitation
with antibodies against CD4 and bgal revealed that the
half-life of bgal (4.1 h) was significantly shorter than that of
CD4 (6.2 h).
Thus, not only was bgal a faithful reporter of CD4 gene
expression, it also appeared to be an early indicator.
bgal as a Marker for CD4 and CD8 Lineage Commitment in
the Thymus. Since bgal appeared to be an early indicator
of CD4 gene transcription, it represented a valuable marker
of lineage commitment during the initial stages of T cell se-
lection in the thymus. Thus, we stained CD41/L thy-
mocytes simultaneously for CD4, CD8, CD3, and bgal. In
Fig. 3 A, CD3hi thymocytes are displayed in a CD4/CD8
plot, and show the customary boomerang-shaped distribu-
tion extending from the mature CD4 SP to the mature
CD8 SP compartments. Several distinct gates were set
within this boomerang to permit us to investigate the activ-
ity of the CD4 gene, as reflected by bgal staining, within
different populations. The terminally differentiated popula-
tions (gates B and C) showed essentially homogeneous pat-
terns of bgal staining: CD4 SP thymocytes were bgal1,
CD8 SP cells bgal2. In contrast, most of the intermediate
populations (gates E, G, and F) contained cells of both
phenotypes, even the small CD3hi subpopulation which
displayed high surface levels of CD4 and CD8 (gate D).
These profiles confirmed the notion that surface coreceptor
levels do not fully and immediately reflect lineage commit-
ment (18, 21), and encouraged us to exploit the bgal
marker for investigating lineage commitment ex vivo un-
der unmanipulated conditions. However, it should be kept
in mind that, although the bgal2 phenotype unambigu-
ously denotes a shut-off of CD4 transcriptional activity in
this context, and thus commitment to the CD8 lineage,
bgal1 populations cannot be interpreted as readily, poten-
tially including cells that have not yet committed to or
those that are already committed to the CD4 lineage.
CD41/L mice were crossed with MHC class II–negative
(II0) animals (25) to allow us to evaluate the commitment
status of MHC class I–reactive CD41CD8int thymocytes,
cells proposed to be transitory intermediates committed to
the CD4 lineage (10). Thymocytes from II0 CD41/L mice
were analyzed as above (Fig. 3 B). The CD41CD8int popu-
Figure 2. Characteristics of the bgal reporter. (A and B) Profile of the
bgal marker in CD41/L mice. Lymph node cells (A) or thymocytes (B)
were analyzed by four-color flow cytometry. Anti-CD4 and anti-CD8
antibodies were used to define and set the analysis gates for the major
populations. The smaller cytograms represent the CD3 and bgal intensi-
ties within each of the CD4/CD8 gates. (C) Turnover of bgal versus
CD4 protein. Thymocytes were labeled in vitro for 1 h with [35S]me-
thionine and chased for the indicated times, and the proteins were precip-
itated using anti-CD4 or anti-bgal antibodies. 100% was defined as the
amount of labeled protein precipitated after 2 h of chase. Half-life was
calculated as follows: t1/2 5 (1/a)log10(1/2) 1 2 h, where a 5 slope. The
half-life of bgal is 3.64 , t1/2 5 4.07 , 4.84; the half-life of CD4 is 5.38 ,
t1/2 5 6.18 , 7.57 at 95% confidence. The combined results of five ex-
periments are shown.2325 Chan et al.
lation (gate E) split clearly into two subsets, bgal1 and
bgal2; there was a significant increase in the bgal2 subset
compared with the same transitional population in the class
II–positive mouse. This result is consistent with the notion
that at least some CD8-committed thymocytes transiently
downmodulate surface CD8 levels after positive selection
(18, 21), but also suggests that a sizeable contingent of
CD4-committed cells can be selected in the absence of
MHC class II molecules.
That CD4-committed thymocytes were selected on MHC
class I (in the absence of class II) molecules is substantiated
in Fig. 4, a five-color cytofluorimetric analysis of the ex-
pression of CD4, CD8, CD3, bgal, and CD69, an early
and transient marker of positive selection (14, 39–41).
When CD691 thymocytes from II0 mice were displayed in
CD3/bgal plots, it seemed that CD4- and CD8-committed
thymocytes could be traced by virtue of their very positions
within this plot. The CD8-committed cells appeared to re-
side chiefly within the CD3hibgallo and bgal2 gates; as they
lost bgal expression, they also began to switch from the tran-
sitional CD41CD8int phenotype to the definitive CD4int
CD81 and CD8 SP phenotypes (compare the CD4/CD8
profiles, gates A and B of Fig. 4). In contrast, only CD41
thymocytes were found within the CD3hibgalhi population
(gate C), well separated from cells along the CD8 pathway.
Although rendered unlikely by the very appearance of
the profiles in Fig. 4, a caveat to these interpretations is that
CD41CD8int cells with high bgal expression may still have
been destined for the CD8 lineage, but just had not yet
downregulated bgal expression. To address this point, we
purified CD41CD8intCD3hibgalhi and CD41CD8intCD3hi
bgallo thymocytes, and compared their CD8 mRNA con-
Figure 3. Expression of the bgal reporter in thymocyte populations.
(A) bgal expression in CD41/L mice. CD3hi thymocytes were gated ac-
cording to their CD4/CD8 expression into distinct populations: CD4 SP
cells (4182), transitional CD41CD8int cells (418int), DP cells (4181),
CD4intCD8int cells (4int8int), intermediate CD4intCD81 cells (4int81), and
CD8 SP cells (4281). Histograms represent the intensity of bgal expres-
sion within each of these CD4/CD8 gates. The mean fluorescence inten-
sity (MFI) values for CD3 expression within the respective bgallo and
bgalhi subsets are shown above each histogram, except in cases where
there are few or no cells within the bgal gates. The separate histogram at
the upper right hand corner represents the intensity of bgal expression for
total DP thymocytes. (B) bgal expression in II0 CD41/L mice. bgal ex-
pression within CD4/CD8 thymocyte subsets of CD41/L mice on an
MHC class II–negative background. Thymocytes were analyzed as in A.
Figure 4. Multiparameter visualization of lineage commitment. Thy-
mocytes from a II0 CD41/L mouse were analyzed after gating on CD691
cells. The lower left panel displays the bgal/CD3 profile of these cells,
from which four populations can be distinguished: cells that express the
highest levels of CD3 but have downregulated bgal expression (A); others
that also express the highest levels of CD3, but have maintained CD4
gene activity, as evidenced by full bgal staining (C); intermediates in the
process of downregulating bgal (B); and immature thymocytes that ex-
press low levels of CD3 and high levels of bgal (D). The CD4/CD8 pro-
files of these populations are shown in the smaller panels.2326 Tagging T Cells of the CD4 Lineage
tent by reverse transcriptase (RT)-PCR (Fig. 5). If the
CD41CD8intbgalhi cells were CD8-committed or even un-
committed, their CD8 mRNA levels should be as high as
those detected in the CD41CD8intbgallo or DP popula-
tions. However, if the CD41CD8intbgalhi thymocytes were
CD4-committed, they should have downregulated CD8
transcription at least to some degree. The latter scenario ap-
pears to be the correct one: CD41CD8intbgalhi thymocytes
expressed on average two- to threefold less CD8 mRNA
than their bgallo counterparts, suggesting that many, if not
all, of the CD41CD8intbgalhi thymocytes in II0 mice were
CD4 committed.
Our original results (10) and those of van Meerwijk and
Germain (16) suggested that a mirror-image population,
committed to the CD8 lineage upon selection on MHC
class II molecules, also exists. However, this interpretation
was questioned in subsequent reports (21, 22, 42). There-
fore, we analyzed b2-microglobulin (b2m)-negative (I0)
mice (43) in which the CD4-bgal reporter had been intro-
duced, allowing a distinction between true CD8-commit-
ted cells and other populations (i.e., DPs, CD4-commit-
ted). The cytometric analysis in Fig. 6 A illustrates that
CD4intCD81CD3hi cells did exist in class I–deficient mice,
albeit at a much lower frequency than their counterparts in
class II–deficient animals, and that they displayed the bgallo
phenotype expected of the CD8 lineage. The low expres-
sion of bgal established that these cells were not contami-
nants from the neighboring CD4intCD8intCD3hi popula-
tion, the great majority of which were bgalhi. Our results
also indicated that the CD4intCD81CD3hi cells were a ho-
mogeneous set, as we did not detect CD4-committed cells
within this population, a result consistent with recent find-
ings from other groups (18, 21, 44, 45).
In the same series of experiments, MHC double-defi-
cient (I0II0) mice with a CD41/L genotype were analyzed
(Fig. 6 B): the CD3hi CD41CD8int and CD4intCD81 thy-
mocyte populations present in II0 and I0 mice, respectively,
were not observed in MHC-deficient animals, in agree-
ment with our previous findings (10); the rare CD3hi cells
were all bgalhi and probably represent nonstandard T lin-
eages (46). This result confirms that the intermediate popu-
lations discussed above require MHC engagement in order
to be positively selected, indicating that a CD4 lineage de-
fault pathway in the absence of MHC recognition does not
exist in vivo.
Two Modes of CD8 Commitment. We wondered whether
all T cells destined for the CD8 lineage transit through the
CD41CD8int stage, and just how early CD8-committed
cells switch off CD4 gene activity. Therefore, we crossed
the CD41/L line with two TCR tg lines expressing differ-
ent MHC class I–restricted receptors: the “HY” TCR (se-
lected on Db) and the “OVA” TCR (selected on Kb) (47,
48). Thymocytes from HY1CD41/L and OVA1CD41/L
mice were stained for CD4, CD8, and bgal in addition to
the appropriate V regions (Fig. 7; panels are gated on
clonotypehi cells, thereby focusing the analysis only on cells
expressing the transgene-encoded receptor). In terms of
bgal expression, the patterns were quite similar in the two
types of animals: downregulation of the bgal marker began
in the DP compartment, and the CD41CD8int population
contained both bgalhi and bgallo cells; from the CD4int
CD8int stage onwards, bgal expression was essentially shut
off. Furthermore, both the timing and levels of TCR ex-
pression, as reflected by CD3 expression (not shown), were
also similar for the two tg lines, not surprising since expres-
sion of both transgenes are driven by the same TCR Vb
promoter (Correia-Neves, M., unpublished results). How-
ever, the HY and OVA mice were strikingly different in
their numbers of intermediate CD41CD8int thymocytes.
Consistent with a previous report (18), there were three to
four times more transitional CD41CD8int thymocytes in
OVA than in HY mice. (Note that the OVA line used here
expresses the same receptor as the OVA–tcr-1 line reported
previously [48], but was generated using a different vector
for transgenesis; that the two behave identically in having a
large CD41CD8int population indicates that this phenotype
Figure 5. CD8 mRNA levels in transitional intermediates. (A) CD3hi
thymocytes from CD41/L mice (CD41 and CD81 populations) and II0
CD41/L mice (CD41CD8intbgalhi, CD41CD8intbgallo), as well as total
CD41CD81 thymocytes from II0 CD41/L animals, were purified and an-
alyzed by RT-PCR for their expression of CD8 mRNA. Cytoplasmic
RNA was prepared, cDNA synthesized, and serial dilutions of the differ-
ent cDNA samples (amount indicated above each lane as cell equivalents)
were used as template for simultaneous PCR amplification using CD8
and TCR-b–specific primers. PCR products were detected by hybridiza-
tion. (B) Results from five RT-PCR experiments where the amount of
PCR product hybridizing to a CD8 probe was quantified, standardized
with the internal TCR-b control, and normalized as fold over DP cells
(defined as 1). The CD8 mRNA ratio of CD41CD8intbgallo to CD41
CD8intbgalhi thymocytes is 2.76 6 0.94.2327 Chan et al.
more convoluted, generating large numbers of CD41
CD8int cells. This also appears to be true when endogenous
TCR gene rearrangements in both transgenic lines are pre-
vented by the SCID, RAG, or TCR Ca mutation (10;
Heath, W., personal communication; Correia-Neves, M.,
unpublished results). Such a dichotomy suggests that there
must be at least two modes (or a continuum) of class
I–restricted CD8 lineage differentiation.
With both class I–restricted TCR tg lines, the CD41
CD8int populations contained bgallo and bgalhi cells. bgallo
cells were most likely CD8-committed, in keeping with re-
sults from cell transfer experiments (18). A key question was
whether the bgalhi cells were just precursors of the CD8-
committed cells or whether they really included a CD4-com-
mitted population as we suspected. If there were CD4-
committed cells, destined to die because they bear mismatched
T cell receptors and coreceptors, it should be possible to
rescue them by restoring surface CD8 expression. Further-
more, the efficiency of the rescue should correlate with the
ability of the TCR to generate the transitional CD41
CD8intbgalhi phenotype. Thus, one would predict that such
a rescue experiment should be more successful in the OVA
than the HY animals, which had previously yielded few
rescued cells (49–51). We tested this prediction by crossing
the HY and OVA lines with a transgenic mouse line ex-
pressing near-physiological levels of the CD8 a and b
chains (CD8aab [42]). Representative CD4/CD8 profiles
of thymocytes and lymph node cells from these crosses are
shown in Fig. 8. As observed previously (49–51), rescue of
CD41(tgCD81) T cells was very limited in the HY mouse;
in striking contrast, close to half of the peripheral clonotypehi
lymphocytes in the OVA cross were of the CD4 lineage.
Thus, there was a direct relationship between the number of
CD41CD8intbgalhi thymocytes and the number of rescued
class I–restricted CD41(tgCD81) cells. We also observed a
significant decrease in the positive selection of OVAhi
thymocytes into the CD8 SP compartment. As the affinity of
the OVA receptor may be quite high for its selecting ligand
Figure 6. Lineage commit-
ment in MHC class I–deficient
and MHC-deficient mice. (A)
bgal expression within defined
CD4/CD8 thymocyte subsets of
CD41/L mice on a b2m2 back-
ground. Thymocytes were ana-
lyzed as described in the legend
to Fig. 3. (B) CD3hi thymocytes
in MHC-deficient mice. CD3hi
thymocytes were stained and
gated according to their CD4/
CD8 expression.
Figure 7. bgal expression in thy-
mocyte populations of HY TCR tg
and OVA TCR tg mice. Thy-
mocytes from HY-TCRtgCD41/L
and OVA-TCRtgCD41/L mice
were analyzed by four-color flow
cytometry. CD4/CD8 profiles of
thymocytes expressing the trans-
gene-encoded TCR (as distin-
guished by T3.70 for the HY TCR
and anti-Va2 for the OVA TCR)
are shown. Thymocyte subpopula-
tions were further defined (see the
legend to Fig. 3) and analyzed for
bgal expression.
is not an artifact of transgene vectors or sites of integration.)
Thus, in the HY system, differentiation towards the CD8
lineage seems to proceed quite directly, from DP to CD4int
CD8int to CD42CD81 cells; with the OVA line, it appears2328 Tagging T Cells of the CD4 Lineage
(18), it is possible that the CD8-committed cells were
deleted due to the higher levels of CD8 expression.
CD4 Lineage Cells in the Absence of CD4. Finally, we made
use of the bgal reporter mice to examine the issue of CD4
lineage commitment in the absence of CD4. Previous stud-
ies had demonstrated a population of MHC class II–
restricted, CD42CD82TCRhi Th cells in CD4-deficient
mice (26, 52–54). Although it was never formally demon-
strated, these cells were quite logically considered to belong
to the CD4 lineage.
We readdressed this issue by analyzing offspring from
crosses of CD4-bgal knock-in mice with one of the origi-
nal CD4 knockout lines (26), comparing profiles of bgal1
cells in heterozygous CD41/L animals with those in fully
deficient CD40/L animals. In a four-color cytofluorimetric
analysis using FDG and antibodies against CD4, CD8, and
CD3, the usual CD4/CD8 profile can be substituted with a
bgal/CD8 profile (Fig. 9). In CD41 mice, the bgal1CD82
cells in the thymus and lymph nodes were essentially all
CD41CD3hi, as expected; on average, they amounted
to 4.0 and 15.1% of total thymocytes and lymphocytes,
respectively. When the same gate was applied to bgal1
CD82 cells from CD4-negative CD40/L mice, the same
populations of CD31 T cells were present (now CD42).
The thymocyte population was only moderately dimin-
ished in number, whereas the reduction was more marked
in the lymph nodes. The bgal1CD82 cells were analyzed
for various surface markers and for their TCR Vb region
usage. Preliminary results indicated that these cells were not
particularly different in CD41 and CD42 mice, implying
that the cells selected in the absence of CD4 were not a
special subset of Th cells (not shown).
These results formally demonstrate that thymocytes can
be selected into the CD4 lineage in the absence of cell sur-
face CD4.
Discussion
The CD4-bgal knock-in mouse line provides an accu-
rate, convenient, and harmless means of monitoring CD4
Figure 8. Rescue of CD4 lineage–committed cells in OVA TCR tg,
but not HY TCR tg, mice upon forced expression of CD8. Thymocytes
and lymph node cells from HY TCR, HY TCR/CD8aab, OVA TCR,
and OVA TCR/CD8aab tg mice were analyzed by three-color flow cy-
tometry using the antibodies anti-CD4, anti-CD8, T3.70 (for the HY
TCR), and anti-Va2 (for the OVA TCR). The CD4/CD8 profiles are
gated on the transgenic TCRhi cells. The percentages are indicated for
CD4-expressing cells within the clonotypehi population.
Figure 9. bgal1 DN cells in CD4-deficient mice. Thymocytes and
lymph node cells from homozygous (CD40/L) and heterozygous (CD41/L)
mice were compared using four-color flow cytometry. Cells were first
plotted for their expression of bgal and CD8. CD81bgal1 cells were
gated and further evaluated for their expression of CD4 and CD3. Per-
centages are of total thymocytes.2329 Chan et al.
gene activity directly ex vivo. Expression of the bgal re-
porter faithfully mimicked CD4 expression, was readily
detectable, and had no detectable immunological conse-
quences. The reporter could be used whether or not the
CD4 molecule itself was present. The choice of reporter
also proved advantageous because the half-life of the bgeo
chimeric protein was significantly shorter than that of CD4,
meaning that bgal activity more closely approximated CD4
gene transcription than surface display of CD4 itself. In this
report, we have exploited the CD4-bgal line to study
CD4/CD8 lineage commitment.
CD4-committed Intermediates in the Absence of MHC Class
II Molecules. For some years, debate on the mechanism of
CD4/CD8 lineage commitment has centered around the
issue of whether commitment is essentially instructive or
selective (49, 55, 56). A crucial distinguishing feature of
these two models is the possibility of transitional popula-
tions, with mismatched receptors and coreceptors in the
latter but not the former. Evidence for such populations
was provided by studies on MHC-deficient and TCR tg
mice and by rescue experiments based on forced expression
of coreceptors (11, 12, 14, 15). However, a key finding in
several of these studies was brought into question because
of results from transfer experiments (18, 19) and coreceptor
reexpression assays (21). In particular, these data were con-
sidered to invalidate the support given the selective model
of lineage commitment by the demonstration of transi-
tional intermediates in class II– and class I–deficient mice.
We now exploit the bgal marker to establish that the
CD41CD8int population from class II–deficient mice in-
cludes cells committed to both the CD4 and CD8 lineages.
CD4-committed cells maintain active CD4 gene transcrip-
tion, whereas CD8-committed cells have turned off the
CD4 gene, as reflected by expression of the bgal reporter
(Figs. 3 B and 5).
It might be argued that the CD41CD8intbgalhi thy-
mocytes seen in class II–deficient mice are just precursors
of the bgallo cells, having not yet shut down transcription
of the CD4 gene. Several observations are inconsistent
with this contention: the low level of CD8 mRNA in
CD41CD8intbgalhi cells compared with their bgallo coun-
terparts, as predicted if they are of the CD4 lineage; the
very position of the bgalhi cells on the bgal/CD3 plot, visi-
bly on a different branch than that of the bgallo cells (Fig.
4); the correlation between the numbers of CD41CD8int
bgalhi cells and the ability of the CD8 transgenes to rescue
the CD4-committed cells in OVA and HY transgenic mice
(Figs. 7 and 8). Finally, we have recently found that alter-
ing the avidity of TCR signaling by introducing a CD5
knockout mutation (57) increases the numbers of CD41
CD8intbgalhi cells in II0 mice, without affecting CD41CD8int
bgallo numbers, a change in ratio incompatible with a sim-
ple precursor/product relationship (Chan, S., manuscript in
preparation).
The data presented here do not really contradict those
from the transfer and coreceptor reexpression studies (18,
19, 21, 22). The transfer experiments (18, 19, 58) demon-
strated that the CD41CD8int population from II0 mice
contained CD8-committed thymocytes, but did not rule
out that it also includes CD4-committed cells because,
having mismatched receptors and coreceptors, these cells
should not have survived in the host wild-type thymus any
better than in the II0 donor. As for the coreceptor reexpres-
sion assays, the data actually did show that cells committed
to both lineages were present within the CD41CD8int pop-
ulation of II0 mice (Fig. 4 A in reference 21). The existence
of CD4-committed cells was discounted by these authors
in favor of a CD4 “default selection” pathway, hypothe-
sized to occur independently of MHC engagement. How-
ever, no evidence for such a pathway has been observed in
several studies (22, 41; Fig. 6 B), so that it appears reason-
able to equate the CD4-committed CD41CD8int cells de-
scribed in this report with those that reexpressed only CD4
after pronase treatment.
The existence of CD4-committed, but class I–reactive,
intermediates is consistent with results from the older ex-
periments forcing expression of coreceptors via transgenesis
(11, 12, 14). Our data (Figs. 7 and 8) extend the older data
by fulfilling, in two TCR transgenic systems, the predic-
tion that the numbers of intermediates with mismatched
receptors and coreceptors should correlate with their ability
to be rescued to full maturity by artificially expressing the
appropriate coreceptor. Our results also explain the range
in observations made in previous rescue experiments, rela-
tively efficient rescue being obtained in some cases (11, 14,
15, 59) but not in others (49, 50). Inefficient rescue has
been cited repeatedly as evidence for instructive or hemi-
instructive models (11, 12, 21). It is clear now that rescue
experiments are not inherently inefficient but one must
choose an appropriate TCR tg system that provides
enough intermediates to be rescued.
The Asymmetry of Commitment. The present data reaf-
firm the existence of CD4 lineage–committed transitional
intermediates that were nudged down the differentiation
pathway by engagement of their TCRs by MHC class I
molecules in the absence of class II molecules. An analo-
gous population of CD8 lineage–committed cells was
hypothesized when CD4intCD81 cells were found in class
I–deficient mice (10, 16), but their existence has been
questioned (20–22, 42). Our findings confirm that transi-
tional intermediates committed to the CD8 lineage in the
absence of MHC class I molecules do exist, as evidenced by
the absence of bgal expression in CD41CD8intCD3hi cells
in I0 mice (Fig. 6 A). This result is consistent with reports
that transgenic mice expressing class II–restricted TCRs
(17, 60) and MHC-deficient mice complemented with
MHC class II genes delivered by an adenovirus vector
injected intrathymically (Rooke, R., manuscript in prepa-
ration) can give rise to mature bona fide CD81 cells. How-
ever, the numbers of CD8-committed transitional interme-
diates in class I–deficient mice are low: 2.3 6 0.9% of the
numbers in normal mice (n 5 5), compared with 20 6 5%
the normal numbers for CD4-committed intermediates in
class II–negative animals. The rarity of the CD4intCD81
cells may explain why they were not detected by other
groups—either because three-color bromodeoxyuridine la-2330 Tagging T Cells of the CD4 Lineage
beling experiments are inherently maladapted for the de-
tection of small populations (42), or because the analysis/
sorting gates that were used included DP cells, thereby mask-
ing the transitional intermediates (20, 21). Thus, CD4/
CD8 lineage commitment seems to exhibit qualitative sym-
metry in that receptor/coreceptor-mismatched commitment
occurs in both pathways, but there is quantitative asymme-
try in that such “mistaken” commitment to the CD4 lineage
is far more frequent than that to the CD8 lineage—actually
somewhat in line with the earlier assertions of asymmetry in
the positive selection process (21, 61).
Asymmetry is also evident in the fact that no CD4-com-
mitted equivalent of CD8-committed CD41CD8int thy-
mocytes (waltzers) has been described. Here, we detected
no bgalhi cells in the CD4intCD81 population, in good agree-
ment with findings from several groups (18, 21, 22). Thus,
while commitment to the CD8 lineage can launch at least
two different modes of differentiation, either direct progres-
sion to the CD42CD81 phenotype as seen for cells in the
HY system, or transit through the CD41CD8int stage as seen
for OVA T cells, commitment to the CD4 lineage seems to
provoke a quite direct progression to the mature SP stage.
Pathways. What explains the diverse modes of differen-
tiation exhibited by the CD8 lineage? A hint may come
from the results of recent analyses of cis-control elements of
the CD8a gene (62, 63) and past studies on CD4 gene
control elements (35, 36, 64). Distinct enhancer elements
promote expression of CD8, and perhaps CD4, in DP ver-
sus mature SP cells; regulation is further complicated by a
silencer located in the CD4 gene. It may be that, concomi-
tant with positive selection, transcriptional activity driven
by the DP cell–specific enhancer is shut off, and then
whether the cells destined to become CD8 SP proceed di-
rectly or transit through the CD41CD8int stage may simply
reflect the speed with which the transcription factors bind-
ing to the “mature” CD8 SP–specific enhancer and/or the
CD4 silencer become operational.
Differential mobilization or demobilization of transcrip-
tion factors could result from different TCR affinities/avid-
ities. It was suggested some time ago that the affinity/avid-
ity of a DP thymocyte’s TCR for the positively selecting
ligand or stromal cells might play a role in determining its
pathway of differentiation (14, 49), and recent data support
this notion (60, 65). It seems likely that the divergent
behaviors of OVA and HY TCR tg thymocytes reflect
different strengths of interaction between the two TCRs
and their positively selecting ligands (18). Pircher and
colleagues have also attributed the differing numbers of
CD41CD8int cells found in the P14 TCR tg line on the
H-2b and H-2bm13 backgrounds to different avidities for the
selecting ligands (13). At present, it is not clear whether
stronger signals promote differentiation along the CD4 or
CD8 pathway, as arguments have been presented on both
sides (14, 49, 60, 66). Thymocyte-extrinsic factors within
the thymus milieu as well as intrinsic factors of a more gen-
eralized nature also play a role in determining cell fate.
Concerning the former, it should be kept in mind that the
thymic stroma is very heterogeneous, containing niches
where the expression of MHC molecules can vary mark-
edly (4, 67); concerning the latter, recent results on Notch
are intriguing (68).
CD4 Lineage Cells in the Absence of CD4. Finally, we con-
firmed that the population of MHC class II–restricted
CD42CD82 T lymphocytes previously observed in CD4-
deficient mice (26, 52–54) do indeed belong to the CD4
lineage. In CD42 mice (CD40/L), a subset of DN a/b T
cells in both the thymus and the peripheral lymphoid or-
gans expresses high levels of bgal (Fig. 9). Thus, commit-
ment to the CD4 lineage does not require the CD4 mole-
cule; in fact, it is quite efficient in its absence. Interestingly,
although the numbers of DN CD31bgal1 thymocytes gen-
erated after selection were quite high (z30% the numbers
in normal mice), their relative abundance was lower in the
periphery (z12%). A possible explanation for this diminu-
tion is that signals from the CD4 molecule contribute (al-
beit in a dispensable fashion) both to the thymic selection
of CD41 T cells and to their later export and persistence in
the peripheral lymphoid organs. This would be consistent
with the idea that maintenance of naive CD41 T cells in
the periphery requires continued “tickling” by MHC mol-
ecules (69, 70).
Conclusions. The results presented here argue that
CD4/CD8 lineage commitment is fundamentally symmet-
rical, in that engagement of either class of MHC molecule
by a differentiating DP thymocyte can give rise to transi-
tional intermediates committed to either lineage. There
does not appear to be a CD4 lineage default pathway, nor
any special requirements to provoke commitment to the
CD8 lineage. Along both routes of differentiation, the ini-
tial lineage choice is validated at a later stage, when only
those cells expressing appropriately matched T cell recep-
tors and coreceptors are permitted to survive.
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